Transthyretin and Receptor for Advanced Glycation End Product’s Differential Levels Associated with the Pathogenesis of Rheumatoid Arthritis
Monu,1,2 Prachi Agnihotri,1 Mohd Saquib,1,2 Ashish Sarkar,1,2 Debolina Chakraborty,1,2 Uma Kumar,3 Sagarika Biswas1 1Council of Scientific and Industrial Research -Institute of Genomics & Integrative Biology (CSIR–IGIB), Delhi, 110007, India; 2Academy of Scientific and Innovative Research (AcSIR...
Enregistré dans:
Auteurs principaux: | Monu, Agnihotri P, Saquib M, Sarkar A, Chakraborty D, Kumar U, Biswas S |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/93dcb46c30934decab06f175b744cf66 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Soluble receptor for advanced glycation end products in critically ill patients and its associations with other clinical markers and 28-day mortality
par: Cheng YZ, et autres
Publié: (2014) -
Fluorescent serum and urinary advanced glycoxidation end-products in non- diabetic subjects
par: DE LA MAZA,MP, et autres
Publié: (2007) -
Advanced glycation end products and oxidative stress as a basis for metabolic abnormalities in patients with type 1 diabetes after successful simultaneous pancreas-kidney transplantation
par: Irina I. Larina, et autres
Publié: (2021) -
Inhibitory effect of lotus seedpod oligomeric procyanidins on advanced glycation end product formation in a lactose-lysine model system
par: Wu,Qian, et autres
Publié: (2015) -
Inhibition of Advanced Glycation End Products in Yogurt by Lotus Seedpod Oligomeric Procyanidin
par: Nianjie Feng, et autres
Publié: (2021)